---
figid: PMC5687693__oncotarget-08-89326-g001
figtitle: Management of intracranial melanomas in the era of precision medicine
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5687693
filename: oncotarget-08-89326-g001.jpg
figlink: /pmc/articles/PMC5687693/figure/F1/
number: F1
caption: BRAF inhibitors (vemurafenib and dabrafenib) and MEK inhibitors (trametinib,
  selumitinib, and binimetinib) target the MAP kinase pathway to check tumor growth.
papertitle: Management of intracranial melanomas in the era of precision medicine.
reftext: Grace J. Young, et al. Oncotarget. 2017 Oct 24;8(51):89326-89347.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9633765
figid_alias: PMC5687693__F1
figtype: Figure
redirect_from: /figures/PMC5687693__F1
ndex: 3cdeaaa0-ded4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5687693__oncotarget-08-89326-g001.html
  '@type': Dataset
  description: BRAF inhibitors (vemurafenib and dabrafenib) and MEK inhibitors (trametinib,
    selumitinib, and binimetinib) target the MAP kinase pathway to check tumor growth.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Sos
  - drk
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Akt
  - Dsor1
  - Mtk
  - Mtor
  - Tor
  - Erk7
  - rl
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - binimetinib
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
